ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-Fmoc-N'-allyoxycarbonyl-L-lysine
C25H28N2O6
452.5 g/mol
Pharmaceutical IntermediateWarning

(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-6-{[(prop-2-en-1-yloxy)carbonyl]amino}hexanoic acid

CAS146982-27-6EC961-773-6
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Fmoc-Lys(Alloc)(Alloc)-OH is a protected amino acid derivative used in solid-phase peptide synthesis. It contains orthogonal protecting groups that allow selective deprotection during peptide chain assembly.

Building block for solid-phase peptide synthesisOrthogonally protected lysine derivative for multi-step peptide assembly

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 1.00

Alloc-Lys(Fmoc)-OH

CAS186350-56-1

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.85

N,N'-Bis-Fmoc-L-lysine

CAS78081-87-5

research compound

SimilarStructure SimilarSimilarity 0.74

Fmoc-N'-Acetyl-L-lysine

CAS159766-56-0

research compound

SimilarStructure SimilarSimilarity 0.72

Fmoc-L-glutamic acid 5-allyl ester

CAS133464-46-7

research compound

ReferenceSame Category

Dapagliflozin Impurity 9

CAS1469910-70-0

pharmaceutical intermediate

ReferenceSame Category

Tert-butyl N-(chlorosulfonyl)carbamate

CAS147000-89-3

pharmaceutical intermediate

ReferenceSame Category

(1R,2S,5R)-Menthyl-(2R,5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic acid

CAS147027-10-9

pharmaceutical intermediate

ReferenceSame Category

(S)-4-N-Boc-2-methylpiperazine

CAS147081-29-6

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-(prop-2-enoxycarbonylamino)hexanoic acid

InChIKey

OJBNDXHENJDCBA-QFIPXVFZSA-N

SMILES

C=CCOC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Synonyms (19)
  • FMOC-LYS(ALOC)-OH
  • Fmoc-L-Lys(Alloc)-OH
  • Fmoc-Lys(Alloc)
  • Fmoc-Lys(Alloc)-OH

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→